(27 days)
Not Found
No
The summary describes a mechanical atherectomy system with a motor and cutter. There is no mention of any software, algorithms, or data processing that would indicate the use of AI or ML. The performance studies focus on mechanical and functional characteristics.
Yes
The 'Intended Use / Indications for Use' states that the device is "in atherectomy of the peripheral vasculature," which is a procedure designed to remove plaque and restore blood flow, thus treating a medical condition.
No
The device is an atherectomy system designed for the removal of plaque from peripheral vasculature, which is a therapeutic rather than a diagnostic function.
No
The device description clearly outlines physical components like a catheter, handle with a battery-powered motor, and a wire support clip, indicating it is a hardware-based medical device.
Based on the provided text, the Phoenix® Atherectomy System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is "atherectomy of the peripheral vasculature." This is a surgical procedure performed within the patient's body to remove plaque from blood vessels.
- Device Description: The description details a mechanical device (catheter, handle, motor, cutter) designed for physical intervention within the body.
- Lack of IVD Characteristics: The text does not mention any components or processes related to testing samples outside the body (in vitro), such as analyzing blood, tissue, or other bodily fluids.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Phoenix Atherectomy System is a therapeutic device used for a surgical procedure.
N/A
Intended Use / Indications for Use
The Phoenix® Atherectomy System is in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.
The Phoenix® Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.
Product codes (comma separated list FDA assigned to the subject device)
MCW
Device Description
The Phoenix Atherectomy System is a sterile, single-use device designed for atherectomy of the peripheral vasculature. The Phoenix Atherectomy System has two main components: the Phoenix Catheter and the Phoenix Handle.
The Phoenix Catheter is a flexible, over-the-wire (OTW), front-cutting Catheter that continuously captures and clears debulked plaque proximally through the Catheter and Handle into a collection reservoir that resides outside the patient. For use, the Phoenix Catheter is inserted into the Phoenix Handle incorporates a self-contained battery-powered motor designed to drive and rotate the cutter of the Phoenix Atherectomy Catheter at its specified rotational speed. The device is activated by an ON/OFF slider switch on the top of the Handle. An accessory, the Phoenix Wire Support Clip, is also supplied and can be used to clip a guidewire torque device in a fixed position relative to the Phoenix Handle. The Catheter, Handle, and Wire Support Clip are each packaged separately as sterile, single-use components of the Phoenix Atherectomy System.
There are multiple models of the Phoenix Catheter. The smaller 1.8mm and 2.2mm Phoenix Catheter models are compatible with 5F and 6F sheaths, respectively, and track directly over the guidewire with no tip deflection capability. The larger 2.4mm Phoenix Catheter is 7F with the tip having deflection capability. All Phoenix Catheter models use the same Phoenix Handle and are compatible with specific commercially available 0.014" exchange length (260 cm or greater) guidewires listed in the product's instructions for use.
This 510(k) includes modifications to the 2.4mm tip diameter Phoenix Deflecting Catheter distal cutter assembly, as well as the Catheter and proximal chassis design to optimize the ease of use, tip deflection capabilities and manufacturability of the device. Table 9-1 summarizes the subject modifications relative to the predicate devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
peripheral vasculature
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
To demonstrate the substantial equivalence of the modified 2.4mm Deflecting Phoenix Atherectomy System to the predicate 2.4mm Deflecting Phoenix Atherectomy System, the performance and technological characteristics were evaluated by completion of the following testing:
- Dimensional and Visual Inspection
- Catheter Sweep & Deflection Span Verification
- Simulated Use
- Comparative Predicate Testing in Simulated Lesion
- Cutter Torque Chain Torque-to-Failure Test
- Functional Outer Shaft Torque Test
- Outer Shaft Torque Test, Deflecting Catheter
- Thrust Bearing Tensile Test
- Outer Shaft to Slider Tensile Test
- Catheter Drive Train Stress Test
- Cutter Stall Test
- Temperature Rise of Catheter During Simulated Use
- Kink Bend Radius Test
- Guidewire Compatibility
- Sheath Compatibility
- Sheath Flow Rate
- Corrosion Resistance
- Large Vessel Debulking Diameter for Deflecting Catheter
- Packaging and Shelf Life
The results from this testing demonstrate that the performance and technological characteristics of the modified Phoenix 2.4mm Deflecting Atherectomy System meet defined design requirements and that the modified device performs in a manner equivalent to the predicate Phoenix 2.4mm Deflecting Atherectomy System with the identical intended use.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.4875 Intraluminal artery stripper.
(a)
Identification. An intraluminal artery stripper is a device used to perform an endarterectomy (removal of plaque deposits from arterisclerotic arteries.)(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 26, 2015
Volcano AtheroMed, Inc. c/o Ms. Jean Chang Vice President, Operations 1455 Adams Drive, Suite 1120 Menlo Park, CA 94025
Re: K151145
Trade/Device Name: Phoenix Atherectomy System Regulation Number: 21 CFR 870.4875 Regulation Name: Intraluminal Artery Stripper Regulatory Class: Class II Product Code: MCW Dated: April 28, 2015 Received: April 29, 2015
Dear Ms. Chang:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
1
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Kenneth J. Cavanaugh -S
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
2
Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017 See PRA Statement below.
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
K151145
Device Name
Phoenix® Atherectomy System
Indications for Use (Describe)
The Phoenix® Atherectomy System is in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
Submitter Information:
| Date of 510(k) Summary Preparation: | April 28, 2015 |
|---|---|
| Name and Address of Manufacturer: | Volcano AtheroMed, Inc. |
| 1455 Adams Dr. | |
| Menlo Park, CA 94025 | |
| Contact Person: | Jean Chang |
| Vice President, Operations | |
| Phone: (650) 473-6846 | |
| Fax: (650) 473-9927 | |
| Subject Device: | |
| Device Trade Name: | Phoenix® Atherectomy System |
| Common Name: | Peripheral Atherectomy Catheter |
| Regulation Description: | Intraluminal Artery Stripper |
| Regulation Number: | 21 CFR 870.4875 |
| Product Code: | MCW |
| Device Class: | Class II |
| Classification Panel: | Cardiovascular |
Predicate Device:
Trade Name: 510(k) Number: Manufacturer:
Phoenix Atherectomy System K132682 & K140944 Volcano AtheroMed, Inc.
4
Device Description:
The Phoenix Atherectomy System is a sterile, single-use device designed for atherectomy of the peripheral vasculature. The Phoenix Atherectomy System has two main components: the Phoenix Catheter and the Phoenix Handle.
The Phoenix Catheter is a flexible, over-the-wire (OTW), front-cutting Catheter that continuously captures and clears debulked plaque proximally through the Catheter and Handle into a collection reservoir that resides outside the patient. For use, the Phoenix Catheter is inserted into the Phoenix Handle incorporates a self-contained battery-powered motor designed to drive and rotate the cutter of the Phoenix Atherectomy Catheter at its specified rotational speed. The device is activated by an ON/OFF slider switch on the top of the Handle. An accessory, the Phoenix Wire Support Clip, is also supplied and can be used to clip a guidewire torque device in a fixed position relative to the Phoenix Handle. The Catheter, Handle, and Wire Support Clip are each packaged separately as sterile, single-use components of the Phoenix Atherectomy System.
There are multiple models of the Phoenix Catheter. The smaller 1.8mm and 2.2mm Phoenix Catheter models are compatible with 5F and 6F sheaths, respectively, and track directly over the guidewire with no tip deflection capability. The larger 2.4mm Phoenix Catheter is 7F with the tip having deflection capability. All Phoenix Catheter models use the same Phoenix Handle and are compatible with specific commercially available 0.014" exchange length (260 cm or greater) guidewires listed in the product's instructions for use.
This 510(k) includes modifications to the 2.4mm tip diameter Phoenix Deflecting Catheter distal cutter assembly, as well as the Catheter and proximal chassis design to optimize the ease of use, tip deflection capabilities and manufacturability of the device. Table 9-1 summarizes the subject modifications relative to the predicate devices.
Indications for Use:
The Phoenix® Atherectomy System is intended for use in atherectomy of the peripheral vasculature. It is not intended for use in coronary, carotid, iliac or renal vasculature.
Testing Summary:
To demonstrate the substantial equivalence of the modified 2.4mm Deflecting Phoenix Atherectomy System to the predicate 2.4mm Deflecting Phoenix Atherectomy System, the performance and technological characteristics were evaluated by completion of the following testing:
- Dimensional and Visual Inspection
- . Catheter Sweep & Deflection Span Verification
- Simulated Use
5
- Comparative Predicate Testing in Simulated Lesion .
- . Cutter Torque Chain Torque-to-Failure Test
- . Functional Outer Shaft Torque Test
- Outer Shaft Torque Test, Deflecting Catheter
- . Thrust Bearing Tensile Test
- Outer Shaft to Slider Tensile Test
- Catheter Drive Train Stress Test
- . Cutter Stall Test
- Temperature Rise of Catheter During Simulated Use
- Kink Bend Radius Test
- Guidewire Compatibility
- . Sheath Compatibility
- . Sheath Flow Rate
- . Corrosion Resistance
- . Large Vessel Debulking Diameter for Deflecting Catheter
- Packaging and Shelf Life
The results from this testing demonstrate that the performance and technological characteristics of the modified Phoenix 2.4mm Deflecting Atherectomy System meet defined design requirements and that the modified device performs in a manner equivalent to the predicate Phoenix 2.4mm Deflecting Atherectomy System with the identical intended use.
6
| Table 9-1: Summary of Technological Characteristics for the Modified Phoenix | ||
|---|---|---|
| Atherectomy System | ||
| Technological | Predicate Phoenix Atherectomy | |
| System (K132682), | Modified Phoenix Atherectomy | |
| System, (Subject Device), | ||
| Characteristic | 7F Phoenix Catheters (FG1179) | 7F Phoenix Catheters (FG1728) |
| Rotational Speed | 10,000-12,000 RPM | Identical |
| Guidewire Exchange | Over-the-wire | Identical |
| Guidewire Compatibility | 0.014" | Identical |
| Sheath Compatibility | 7F | Identical |
| Catheter Working Length | 130 cm | 127 cm Straight |
| 117 cm Deflected | ||
| Catheter Torque Shaft | Multi-Strand Stainless Steel (SS) | Multi-Strand Stainless Steel (SS) |
| Catheter Inner Shaft | Stainless Steel Outer Shaft and | |
| Teflon Sheath | Stainless Steel Outer Shaft and Thicker | |
| Teflon sheath | ||
| Catheter Outer Shaft | Stainless Steel Outer Shaft and | |
| Teflon sheath | Identical | |
| Catheter Shaft Diameter | 2.2mm | Identical |
| Distal Cutter Flute | ||
| Maximum Diameter | 2.3mm | 2.4mm |
| Tip Diameter and | ||
| Crossing Profile | 2.4mm | Identical |
| Cutting Tip Port | None | Single exit port conveys excised debris |
| from the inner guidewire lumen into the | ||
| Distal Cutting Flute channel | ||
| Second Stage | ||
| Maceration within | ||
| Housing | Yes | Identical |
| Cutter Housing | Coating | No Coating |
| Distal Tip Assembly | ||
| Coating | Yes | Yes |
| Minimum Vessel Size for | ||
| Device Use | 3.0mm | Identical |
| Deflection span | ||
| (Side-to-side) | ≥ 5.5mm | ≥ 6.0mm |
| Deflection Mechanism | Knob Advances/Retracts Inner Shaft | |
| to straighten or buckle inner Nitinol | ||
| tube for deflection | Slider Advances/Retracts the Outer | |
| Shaft with the pre-shaped Nitinol | ||
| section at the distal end to deflect or | ||
| straighten the tip of the Inner Shaft | ||
| housing the cutter assembly | ||
| Debris Collection & | ||
| Removal | Continuous collection and removal of | |
| excised debris by mechanical | ||
| conveyance | Identical | |
| Steering (Directional) | ||
| mechanism | Rotation of knob steers distal tip and | |
| cutter by torqueing Catheter Inner | ||
| Shaft | Identical Mechanism: Rotation of knob | |
| steers distal tip and cutter by torqueing | ||
| Catheter Outer Shaft | ||
| Catheter Coating | No | Identical |
| Sterilization | Ethylene Oxide | Identical |
| Single-use only | Yes | Identical |